Preliminary evidence of renal function improvement in chronic progressive kidney disease using autologous CD34+ cell therapy: A clinical trial

doi:10.4252/wjsc.v16.i12.1012

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 12

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (586)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-3) series.

Item

Count

PDF

HTML

259

Figures (1-3)

Tables (1-3)

Sum=339

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

109

Sum=175

Publishing Process of This Article

Item

Count

Browse

Download

Sum=55

Dec 26, 2024 (publication date) through Jan 3, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Trials Study

World J Stem Cells. Dec 26, 2024; 16(12): 1012-1021
Published online Dec 26, 2024. doi: 10.4252/wjsc.v16.i12.1012

Table 3 Adverse events

	Adverse event	CTCAE grade	Treatment	Related factor
Case 2	Left hip joint pain and left femoral bone pain	Grade 1	Acetaminophen	G-CSF
Case 3	Fever	Grade 1	Acetaminophen	First cell therapy
	Fever	Grade 1	No treatment	Second cell therapy
	Left knee joint arthritis	Grade 2	Aspiration of fluid	Accidental symptom
	COVID-19 infection	Grade 2	Molnupiravir	COVID-19 epidemic

CTCAE: Common Terminology Criteria for Adverse Events; G-CSF: Granulocyte colony-stimulating factor; COVID-19: Coronavirus disease 2019.

Citation: Ohtake T, Sato T, Tsukiyama T, Muraoka S, Mitomo A, Maruyama H, Yamano M, Mochida Y, Ishioka K, Oka M, Moriya H, Hidaka S, Masuda H, Asahara T, Kobayashi S. Preliminary evidence of renal function improvement in chronic progressive kidney disease using autologous CD34⁺ cell therapy: A clinical trial. World J Stem Cells 2024; 16(12): 1012-1021
URL: https://www.wjgnet.com/1948-0210/full/v16/i12/1012.htm
DOI: https://dx.doi.org/10.4252/wjsc.v16.i12.1012